ARCOSA INC (ACA) Forecast, Price Target & Analyst Ratings

Q: What do analysts expect the price target to be for ARCOSA INC (ACA)?

10 analysts have analysed ACA and the average price target is 130.39 USD. This implies a price increase of 4.8% is expected in the next year compared to the current price of 124.415.

NYSE:ACA • US0396531008

124.415 USD

-2.05 (-1.62%)

Last: May 1, 2026, 11:48 AM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ARCOSA INC (ACA).

Consensus Price Target

Price Target

$130.39

+ 4.80% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: N/A
Period: Q2 / 2026
EPS Estimate: $1.43
Revenue Estimate: 786.29M

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

84.00%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

$130.39

Upside

+ 4.80%

From current price of $124.42 to mean target of $130.39, Based on 10 analyst forecasts

Low

$116.15

Median

$132.09

High

$141.75

Price Target Revisions

1 Month

3.76%

3 Months

3.26%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for ACA. The average price target is 130.39 USD. This implies a price increase of 4.8% is expected in the next year compared to the current price of 124.415.

The average price target has been revised upward by 3.26% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

84.00%

ACA was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ACA.

In the previous month the buy percentage consensus was at a similar level.

ACA was analyzed by 10 analysts. More opinions would make the average more meaningful.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2026-03-02	DA Davidson	Maintains	Buy -> Buy
2025-11-03	Barclays	Maintains	Overweight -> Overweight
2025-08-11	DA Davidson	Maintains	Buy -> Buy
2025-01-14	Oppenheimer	Maintains	Outperform -> Outperform
2024-10-29	Barclays	Initiate	Overweight
2024-08-19	Oppenheimer	Maintains	Outperform -> Outperform
2024-08-07	Stephens & Co.	Upgrade	Equal-Weight -> Overweight
2024-05-17	DA Davidson	Maintains	Buy -> Buy
2024-02-28	DA Davidson	Maintains	Buy -> Buy
2024-02-23	Oppenheimer	Maintains	Outperform -> Outperform
2023-10-17	Sidoti & Co.	Upgrade	Neutral -> Buy
2023-08-08	Stephens & Co.	Maintains	Equal-Weight -> Equal-Weight
2023-08-07	DA Davidson	Maintains	Buy -> Buy
2023-08-07	Loop Capital	Maintains	Buy -> Buy
2023-05-08	Oppenheimer	Maintains	Outperform
2023-05-01	DA Davidson	Maintains	Buy
2023-05-01	Loop Capital	Maintains	Buy
2023-02-27	DA Davidson	Maintains	Buy
2022-11-08	Stephens & Co.	Downgrade	Overweight -> Equal-Weight
2022-08-08	Stephens & Co.	Maintains	Overweight
2021-11-02	Loop Capital	Initiate	Buy
2021-10-05	Berenberg	Initiate	Buy
2021-07-26	Sidoti & Co.	Upgrade	Neutral -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date: N/A
Period: Q2 / 2026
EPS Estimate: $1.43
Revenue Estimate: 786.29M
Revenue Q2Q: 6.70%
EPS Q2Q: 12.43%
Number of Analysts: 7

Next Earnings Revisions

Revenue (1 Month)

0.86%

Revenue (3 Months)

-2.96%

EPS (1 Month)

-0.62%

EPS (3 Months)

-19.37%

Next Earnings Summary

The next earnings revenue estimate has been revised downward by 2.96% in the past 3 months.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2023	2024	2025	2026	2027
Revenue YoY % growth	2.308B 2.90%	2.57B 11.35%	2.883B 12.20%	3.035B 5.26%	3.232B 6.49%
EBITDA YoY % growth	342.2M 8.95%	390.2M 14.03%	548.4M 40.54%	617.33M 12.57%	657.85M 6.56%
EBIT YoY % growth	182.7M 14.19%	195.2M 6.84%	325.4M 66.70%	382.69M 17.61%	418.82M 9.44%
Operating Margin	7.92%	7.60%	11.29%	12.61%	12.96%
EPS YoY % growth	3.23 46.82%	3.01 -6.81%	4.47 48.50%	4.83 8.02%	5.64 16.70%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q2 / 26	Q3 / 26	Q4 / 26	Q1 / 27	Q2 / 27	Q3 / 27	Q4 / 27
EPS Q2Q % growth	1.43 12.43%	1.76 13.10%	1.22 5.93%	0.56 8.92%	1.65 15.54%	1.95 10.49%	1.33 9.16%
Revenue Q2Q % growth	786.29M 6.70%	844.24M 5.82%	752.07M 4.94%	693.87M 21.37%	829.82M 5.54%	903.45M 7.01%	804.16M 6.93%
EBITDA Q2Q % growth	167.96M -17.18%	187.36M -31.14%	154.45M -48.50%	116.86M 13.65%	174.12M 3.67%	198.26M 5.82%	168.06M 8.81%
EBIT Q2Q % growth	106.58M 14.48%	127.36M 19.92%	95.748M 24.51%	57.267M 16.25%	114.53M 7.46%	138.67M 8.88%	108.47M 13.29%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

N/A

EPS Next 5 Year

N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

N/A

Revenue Next 5 Year

N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

N/A

EBIT Next 5 Year

N/A

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ARCOSA INC / ACA Forecast FAQ

What do analysts expect the price target to be for ARCOSA INC (ACA)?

10 analysts have analysed ACA and the average price target is 130.39 USD. This implies a price increase of 4.8% is expected in the next year compared to the current price of 124.415.

Can you provide the consensus estimates for ARCOSA INC next earnings?

The consensus EPS estimate for the next earnings of ARCOSA INC (ACA) is 1.43 USD and the consensus revenue estimate is 786.29M USD.

Analyst forecast overview

Forecast Snapshot